Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy
Chesney Michels, Claire Guéguen
Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies
Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz
Optimizing plasmid DNA purification: strategies for reliable and expandable processes
Christy Franco, Jasmina Puc
Non-viral GMP manufacturing for engineered cells at clinical and commercial scale
Leif Anderson, Chris Abraham
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization
Leisha Kopp, Mason Bonitz
Navigating the transition from research to clinical-scale cell therapy manufacture
Steven Feldman, Johannes Fruehauf, Mary Ann Santos